{"id":7458,"date":"2022-11-15T09:18:58","date_gmt":"2022-11-15T09:18:58","guid":{"rendered":"https:\/\/touchimmunology.com\/?post_type=media_gallery&p=7458"},"modified":"2023-02-16T15:51:45","modified_gmt":"2023-02-16T15:51:45","slug":"lisa-christ-acr-2022-tocilizumab-and-ultra-short-glucocorticoids-in-giant-cell-arteritis-one-year-follow-up-of-gusto","status":"publish","type":"media_gallery","link":"https:\/\/touchimmunology.com\/rheumatology\/conference-hub\/lisa-christ-acr-2022-tocilizumab-and-ultra-short-glucocorticoids-in-giant-cell-arteritis-one-year-follow-up-of-gusto\/","title":{"rendered":"Lisa Christ, ACR 2022: Tocilizumab and ultra-short glucocorticoids in giant cell arteritis – one year follow-up of GUSTO"},"content":{"rendered":"

The GUSTO trial (NCT03745586<\/a>) investigated the efficacy and safety of tocilizumab (TCZ )-monotherapy after ultra-short glucocorticoid treatment in new-onset giant cell arteritis (GCA). touchIMMUNOLOGY caught up with Dr. Lisa Christ<\/strong> (University of Bern, Inselspital, Bern, Switzerland) to discuss this analysis of GUSTO exploring the maintenance of remission 1 year after discontinuation of TCZ treatment.<\/p>\n

This information is brought to you by Touch Medical Media and is not sponsored by, nor a part of, the American College of Rheumatology.<\/b><\/p>\n

The abstract \u2018Long-term Efficacy of Tocilizumab Monotherapy After Ultra-short Glucocorticoid Administration to Treat Giant Cell Arteritis \u2013 One Year Follow-up of the GUSTO Trial<\/em><\/a>.\u2019 (Abstract number: 0470) was presented at the\u00a0ACR Convergence<\/a>, November 10\u201314, 2022.<\/p>\n

Questions<\/b><\/p>\n

    \n
  1. What is known about the efficacy and safety of tocilizumab in the treatment of giant cell arteritis (GCA)? (0:16)<\/span><\/li>\n
  2. Could you give us a brief overview of the GUSTO trial and its findings? (1:08)<\/span><\/li>\n
  3. What were the objectives of the current analysis of the GUSTO trial? (2:12)<\/span><\/li>\n
  4. What were the findings of this analysis? (2:41)<\/span><\/li>\n
  5. Why was the relapse rate lower than those reported in earlier clinical trials? (3:12)<\/span><\/li>\n<\/ol>\n

    Disclosures:<\/b> Lisa Christ discloses receiving grant\/ research support from F. Hoffmann-La Roche, Gilead Sciences, and Pfizer; serving on advisory boards for Bristol-Myers Squibb and Novartis; and other financial support from F. Hoffmann-La Roche, Bristol-Myers Squibb, and Sanofi.<\/p>\n

    Support:<\/b> Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Atiya Henry<\/p>\n

    Filmed in coverage of the ACR Convergence 2022.<\/i><\/b><\/p>\n","protected":false},"excerpt":{"rendered":"

    The GUSTO trial (NCT03745586) investigated the efficacy and safety of tocilizumab (TCZ )-monotherapy after ultra-short glucocorticoid treatment in new-onset giant cell arteritis (GCA). touchIMMUNOLOGY caught up with Dr. Lisa Christ (University of Bern, Inselspital, Bern, Switzerland) to discuss this analysis of GUSTO exploring the maintenance of remission 1 year after discontinuation of TCZ treatment. This […]<\/p>\n","protected":false},"featured_media":7466,"template":"","class_list":["post-7458","media_gallery","type-media_gallery","status-publish","has-post-thumbnail","hentry","vocabulary_1-rheumatology","vocabulary_1-vasculitis","video_categories-acr-highlights"],"acf":[],"_links":{"self":[{"href":"https:\/\/touchimmunology.com\/wp-json\/wp\/v2\/media_gallery\/7458"}],"collection":[{"href":"https:\/\/touchimmunology.com\/wp-json\/wp\/v2\/media_gallery"}],"about":[{"href":"https:\/\/touchimmunology.com\/wp-json\/wp\/v2\/types\/media_gallery"}],"version-history":[{"count":14,"href":"https:\/\/touchimmunology.com\/wp-json\/wp\/v2\/media_gallery\/7458\/revisions"}],"predecessor-version":[{"id":9407,"href":"https:\/\/touchimmunology.com\/wp-json\/wp\/v2\/media_gallery\/7458\/revisions\/9407"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/touchimmunology.com\/wp-json\/wp\/v2\/media\/7466"}],"wp:attachment":[{"href":"https:\/\/touchimmunology.com\/wp-json\/wp\/v2\/media?parent=7458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}